OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2016
(3)
2019
(1)
2017
(1)
2015
(1)
2014
(1)
2012
(1)
2011
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Exogenous and endogenous attention during perceptual learning differentially affect post-training target thresholds.
Not available
S-EPMC3268656
|
biostudies-literature
Cite
Predictors of recurrence in the management of chordoid meningioma.
Not available
S-EPMC4684776
|
biostudies-literature
Cite
Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy.
Not available
S-EPMC5124417
|
biostudies-literature
Cite
Immunomonitoring in glioma immunotherapy: current status and future perspectives.
Not available
S-EPMC4867303
|
biostudies-literature
Cite
Strong Correlation of Genome-Wide Expression after Traumatic Brain Injury In Vitro and In Vivo Implicates a Role for SORLA.
Not available
S-EPMC5198072
|
biostudies-literature
Cite
Metabolic response of glioblastoma to superselective intra-arterial cerebral infusion of bevacizumab: a proton MR spectroscopic imaging study.
Not available
S-EPMC7965590
|
biostudies-literature
Cite
Cost-effectiveness of CT angiography and perfusion imaging for delayed cerebral ischemia and vasospasm in aneurysmal subarachnoid hemorrhage.
Not available
S-EPMC4161647
|
biostudies-literature
Cite
Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis.
Not available
S-EPMC4280234
|
biostudies-literature
Cite
Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.
Not available
S-EPMC6571046
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets